Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Rustin

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Cancer|February 1, 1992
Gestational and nongestational trophoblastic tumors distinguished by DNA analysisR A Fisher, E S Newlands, A J Jeffreys, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I study of intravenous 4-hydroxyanisoleG J Rustin, M R Stratford, A Lamont, et al.
British Journal of Cancer|July 4, 1998
High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factorsM P Lyttelton, E S Newlands, C Giles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Secondary tumours following etoposide containing therapy for germ cell cancerC Boshoff, R H Begent, R T Oliver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125G J Rustin, A E Nelstrop, P McClean, et al.
British Journal of Cancer|January 1, 1991
In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in manP A Philip, K D Bagshawe, F Searle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125G J Rustin, A E Nelstrop, M Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumorsG J Rustin, E S Newlands, J M Lutz, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomasD B Smith, J A Ledermann, E Boesen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Placental site trophoblastic tumor: molecular analysis and clinical experienceM Bower, F J Paradinas, R A Fisher, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Cancer|February 1, 1992
Gestational and nongestational trophoblastic tumors distinguished by DNA analysisR A Fisher, E S Newlands, A J Jeffreys, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I study of intravenous 4-hydroxyanisoleG J Rustin, M R Stratford, A Lamont, et al.
British Journal of Cancer|July 4, 1998
High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factorsM P Lyttelton, E S Newlands, C Giles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Secondary tumours following etoposide containing therapy for germ cell cancerC Boshoff, R H Begent, R T Oliver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125G J Rustin, A E Nelstrop, P McClean, et al.
British Journal of Cancer|January 1, 1991
In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in manP A Philip, K D Bagshawe, F Searle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125G J Rustin, A E Nelstrop, M Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumorsG J Rustin, E S Newlands, J M Lutz, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomasD B Smith, J A Ledermann, E Boesen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Placental site trophoblastic tumor: molecular analysis and clinical experienceM Bower, F J Paradinas, R A Fisher, et al.
Pageof 16